Search results for CD8 Antibody

Anti-Human CD8 Antibody (63H6), FITC (HP158217), abinScience, HP158217

Anti-Human CD8 Antibody (53F6), PE (HP158327), abinScience, HP158327

Anti-Human CD8 Antibody (53F6), FITC (HP158317), abinScience, HP158317

Anti-Human CD8 Antibody (53F6), PerCP (HP158347), abinScience, HP158347

Anti-Mouse CD8 Antibody (MSE10), PE (MP158127), abinScience, MP158127

Alexa Fluor® 555 Anti-CD8 antibody [SP239], Abcam, AB313283

What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

PerCP/Cy5.5® Anti-CD8 antibody [MEM-31], Abcam, AB157306

ab157306 does not react with formaldehyde-fixed cells.

APC/Cy7® Anti-CD8 antibody [MEM-31], Abcam, AB233300

This product or portions thereof is manufactured under license from Carnegie Mellon University under U.S. Patent Number 5, 268, 486 and related patents. Cy® and CyDye® are trademarks of Cytiva.

Alexa Fluor® 568 Anti-CD8 antibody [SP239], Abcam, AB313089

What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Pacific Blue anti-human CD8 Antibody anti- - SK1, BioLegend, 980906